CStone Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	988	365	335	662	1,086	1,223
Market Cap Growth	170.62%	8.89%	-49.38%	-39.01%	-11.19%	2.46%
Enterprise Value	953	295	234	505	750	966
Last Close Price	0.66	0.27	0.24	0.53	0.89	1.02
PS Ratio	41.06	6.78	5.67	10.14	32.19	9.40
PB Ratio	26.39	7.58	5.75	10.87	6.50	3.31
P/TBV Ratio	52.12	13.62	9.26	16.86	6.90	3.31
EV/Sales Ratio	39.53	5.48	3.95	7.73	22.22	7.43
Debt / Equity Ratio	1.24	0.98	0.80	0.64	0.14	0.03
Net Debt / Equity Ratio	-0.95	-1.00	-1.50	-1.92	-1.33	-1.18
Net Debt / EBITDA Ratio	0.84	4.43	1.22	0.96	0.88	3.21
Net Debt / FCF Ratio	0.69	1.06	1.16	1.41	1.02	6.06
Asset Turnover	0.15	0.27	0.28	0.25	0.08	0.31
Inventory Turnover	1.38	0.85	2.44	4.86	-	-
Quick Ratio	1.20	1.18	1.44	1.29	2.03	4.91
Current Ratio	1.44	1.60	1.56	1.32	2.10	4.91
Return on Equity (ROE)	-96.36%	-22.23%	-81.05%	-109.00%	-92.28%	-44.92%
Return on Assets (ROA)	-16.93%	-3.90%	-21.93%	-29.16%	-37.90%	-20.33%
Return on Capital Employed (ROCE)	-65.20%	-13.40%	-71.40%	-131.80%	-136.70%	-36.00%
Earnings Yield	-4.54%	-3.31%	-13.98%	-18.49%	-24.47%	-12.50%
FCF Yield	-	-12.44%	-22.41%	-12.51%	-20.08%	-5.89%
Buyback Yield / Dilution	-1.61%	-1.04%	-7.69%	-0.66%	-11.39%	-20.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.